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‘Reckless beyond description.’ 
The words of former World Anti-Doping Agency president Dick 
Pound in light of Maria Sharapova’s shock announcement this 
week that she tested positive at the Australian Open for the 
banned substance meldonium.
Poignantly, Pound then added: "Running a $30m business 
depends on you staying eligible to play tennis."
This was a reference to Sharapova’s position as the most 
marketable female sports star on the planet. 
The Russian tennis player has topped the Forbes rich list as the 
world’s highest paid female athlete for a remarkable 11 
consecutive years. 
Between June 2014 and June 2015 she banked a staggering 
$29.7m. That’s almost a quarter of the $124m accumulated 
through prize money and endorsements by the top 10 highest paid
female athletes during the same period. 
And this despite being some way off the pace of world number 
one, Serena Williams. Indeed, Sharapova will be ranked seventh 
in the world when the International Tennis Federation imposes a 
provisional suspension this weekend (March 12). 
According to Forbes, only $6.7m of Sharapova’s earnings during 
that 12 month period came from winnings. The rest is from 
commercial deals.  
And this is where Pound’s condemnation of the player’s failed drug
test really starts to resonate.
No sooner had Sharapova took to the podium in a Los Angeles 
hotel to deliver a meticulously prepared speech revealing the error 
of her ways than several major sponsors decided to put some 
daylight between their brand and the five times grand slam winner.
Swiss luxury watchmaker Tag Heuer, who have enjoyed a 
reciprocally healthy relationship with Sharapova since she won 
Wimbledon as a 17-year-old in 2004, were quick to announce they 
were no longer in negotiations with her. Then there was Porsche, 
the German car manufacturer stating it was ‘postponing planned 
activities’ with the client who became its first female ambassador 
three years ago. 
But perhaps the biggest blow came from Nike. Despite its 17-year 
relationship with Sharapova, the sportswear giant was quick to 
announce: “We have decided to suspend our relationship with 
Maria while the investigation continues.”
Added Nike: “We will continue to monitor the situation.” 
Take special note of that last comment. 
All of this was within 24-hours of Sharapova’s revelation. The 
swiftness of the response says much about the power commercial 
sponsors now exert over high profile athletes. 
In return for their millions, they expect reputations to be squeaky 
clean. 
Or do they? 
Commenting on the speed at which brands now act in the face of 
negative publicity, independent sports consultant Nigel Currie said:
"They are paranoid about their image, and the slightest risk to their
image, they run to the hills."
This is true in part but not absolute. 
Naturally, there are those cut and dried cases where the 
punishment befits the crime. 
Take Adidas’ quick and decisive action to drop Adam Johnson last 
month when the former Sunderland and Manchester City footballer
pleaded guilty to child sex offences. 
Also see Nike’s termination of its contract with eight-weight world 
boxing champion Manny Pacquiao in the wake of his ‘worse than 
animals’ comments about same-sex relationships late last year. 
But there have been cases where sponsors, and Nike in particular, can 
be seen to operate on the basis of contradictory moral standards when 
it comes to sports stars. 
Nike was one of several brands that stood by Tiger Woods when the 
married golfer was caught at the centre of a highly publicized sex 
scandal in 2009.  
Contrary to Pacquiao, whose career was on the wane when Nike cut its 
ties, 14 times major winner Woods was at the peak of his powers seven
years ago and, according to Nike, still good for the brand’s image, 
despite the father-of-two’s extra-marital misdemeanors.  
Perhaps more salient for Sharapova is Nike’s decision to renew its 
relationship with Justin Gatlin last year; the US sprinter twice banned for
using performance enhancing drugs, including a four-year suspension 
between 2006-2010. 
It was a commercial deal that was criticized beyond athletics but one 
that Sharapova may now cling to as she waits for a decision on her 
imminent ban. 
This could be anywhere between two or four years, though the player’s 
legal team has suggested a negotiated reduction of less than a year 
based on precedents already set within tennis and the degree of 
innocence on Sharapova’s part. 
Cynical or otherwise, the player’s pre-emptive strike to come clean 
before the world’s media may have done little harm on that front. 
However, with her 29th birthday in April, time may not be on Sharapova’s
side. 
But then Gatlin was in his early thirties when he posted the three fastest
100m times in the world in 2014, form that saw Nike come calling again 
regardless of his murky past. 
The length of Sharapova’s ban is likely to determine whether she plays 
top-level tennis again. Should she make a successful return to the 
sport, don’t be too surprised to see her climbing back toward the top of 
the Forbes rich list. 
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